• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用瞬时弹性成像(TE)联合受控衰减参数(CAP)评估中性粒细胞与淋巴细胞比值在非酒精性脂肪性肝病中的诊断价值。

Diagnostic Value of Neutrophil to Lymphocyte Ratio in Non-Alcoholic Fatty Liver Disease Evaluated Using Transient Elastography (TE) with Controlled Attenuated Parameter (CAP).

作者信息

Lesmana Cosmas Rinaldi Adithya, Kencana Yoppi, Rinaldi Ikhwan, Kurniawan Juferdy, Hasan Irsan, Sanityoso Sulaiman Andri, Gani Rino Alvani

机构信息

Department of Internal Medicine, Hepatobiliary Division, Dr. Cipto Mangunkusumo National General Hospital, Universitas Indonesia, Jakarta, Indonesia.

Digestive Disease & GI Oncology Center, Medistra Hospital, Jakarta, Indonesia.

出版信息

Diabetes Metab Syndr Obes. 2022 Jan 5;15:15-22. doi: 10.2147/DMSO.S330526. eCollection 2022.

DOI:10.2147/DMSO.S330526
PMID:35023936
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8743379/
Abstract

BACKGROUND

Non-alcoholic fatty liver disease (NAFLD) is a chronic inflammatory disease with excessive fat accumulation in the liver. Transient elastography (TE) with controlled attenuation parameter (CAP) is a device and method to examine the degree of fibrosis and steatosis. However, this device is not widely available across Indonesia. Neutrophil and lymphocyte ratio (NLR) is a simple marker for inflammation, which has a potency to predict disease outcome. This study aims to know the diagnostic value of NLR as the indicator of steatosis and fibrosis severity.

METHODS

This was a cross-sectional study with consecutive sample collection. We used secondary data from medical records, starting from 2016 to 2018. A descriptive and data analysis, including correlation test, multivariate linear regression, -test, receiver operating curve (ROC) and area under the curve (AUC) were done to find out the outcome of the study. Statistical analyses were performed using Statistical Package for Social Sciences (SPSS) Version 20.0 (SPSS Inc, Chicago, Illinois). A P value <0.05 was considered as statistically significant.

RESULTS

Out of 106 subjects, 62.3% patients were women with the mean of age 57.29 years old and 77.4% had metabolic syndrome. Most patients had moderate to severe steatosis degree (66%) with the mean of TE mean 6.14 (2.8-18.2) kPa. There was a positive correlation between CAP and TE compared with NLR with r = 0.648 (p < 0.001) and r = 0.621 (p < 0.001), respectively. The use of RNL to assess moderate-severe steatosis has a cutoff point of 1.775 with sensitivity, specificity, PPV and NPV, respectively, at 81.5%, 80.6%, 89.1%, and 69.1%; cutoff point 2.150 to assess significant fibrosis with sensitivity, specificity, PPV and NPV of 92.3%, 87.5%, 70.6%, and 97.2%, respectively.

CONCLUSION

NLR has a positive and significant correlation with the degree of steatosis and fibrosis with high sensitivity and specificity as evaluated by TE/CAP.

摘要

背景

非酒精性脂肪性肝病(NAFLD)是一种肝脏中脂肪过度蓄积的慢性炎症性疾病。带有受控衰减参数(CAP)的瞬时弹性成像(TE)是一种用于检查纤维化和脂肪变性程度的设备和方法。然而,该设备在印度尼西亚并未广泛普及。中性粒细胞与淋巴细胞比值(NLR)是一种简单的炎症标志物,具有预测疾病预后的潜力。本研究旨在了解NLR作为脂肪变性和纤维化严重程度指标的诊断价值。

方法

这是一项采用连续样本采集的横断面研究。我们使用了2016年至2018年病历中的二手数据。进行了描述性分析和数据分析,包括相关性检验、多元线性回归、t检验、受试者工作特征曲线(ROC)和曲线下面积(AUC),以得出研究结果。使用社会科学统计软件包(SPSS)20.0版(SPSS公司,伊利诺伊州芝加哥)进行统计分析。P值<0.05被认为具有统计学意义。

结果

在106名受试者中,62.3%为女性,平均年龄57.29岁,77.4%患有代谢综合征。大多数患者有中度至重度脂肪变性(66%),TE平均值为6.14(2.8 - 18.2)kPa。与NLR相比,CAP与TE之间存在正相关,r分别为0.648(p < 0.001)和0.621(p < 0.001)。使用RNL评估中度至重度脂肪变性的截断点为1.775,其敏感性、特异性、阳性预测值和阴性预测值分别为81.5%、80.6%、89.1%和69.1%;截断点2.150用于评估显著纤维化,其敏感性、特异性、阳性预测值和阴性预测值分别为92.3%、87.5%、70.6%和97.2%。

结论

通过TE/CAP评估,NLR与脂肪变性和纤维化程度呈正相关且具有高度敏感性和特异性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83d9/8743379/9a7c2299c531/DMSO-15-15-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83d9/8743379/62ef45c455e2/DMSO-15-15-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83d9/8743379/9a7c2299c531/DMSO-15-15-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83d9/8743379/62ef45c455e2/DMSO-15-15-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83d9/8743379/9a7c2299c531/DMSO-15-15-g0002.jpg

相似文献

1
Diagnostic Value of Neutrophil to Lymphocyte Ratio in Non-Alcoholic Fatty Liver Disease Evaluated Using Transient Elastography (TE) with Controlled Attenuated Parameter (CAP).利用瞬时弹性成像(TE)联合受控衰减参数(CAP)评估中性粒细胞与淋巴细胞比值在非酒精性脂肪性肝病中的诊断价值。
Diabetes Metab Syndr Obes. 2022 Jan 5;15:15-22. doi: 10.2147/DMSO.S330526. eCollection 2022.
2
Prospective comparison of transient elastography, MRI and serum scores for grading steatosis and detecting non-alcoholic steatohepatitis in bariatric surgery candidates.对肥胖症手术候选者的肝脂肪变性分级及非酒精性脂肪性肝炎检测中瞬时弹性成像、磁共振成像和血清评分的前瞻性比较
JHEP Rep. 2021 Sep 30;3(6):100381. doi: 10.1016/j.jhepr.2021.100381. eCollection 2021 Dec.
3
Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography.磁共振成像比瞬时弹性成像更能准确地对非酒精性脂肪性肝病患者的脂肪变性和纤维化进行分类。
Gastroenterology. 2016 Mar;150(3):626-637.e7. doi: 10.1053/j.gastro.2015.11.048. Epub 2015 Dec 8.
4
Magnetic Resonance Imaging-Proton Density Fat Fraction vs. Transient Elastography-Controlled Attenuation Parameter in Diagnosing Non-alcoholic Fatty Liver Disease in Children and Adolescents: A Meta-Analysis of Diagnostic Accuracy.磁共振成像-质子密度脂肪分数与瞬时弹性成像-受控衰减参数在诊断儿童和青少年非酒精性脂肪性肝病中的比较:诊断准确性的Meta分析
Front Pediatr. 2022 Jan 11;9:784221. doi: 10.3389/fped.2021.784221. eCollection 2021.
5
Serum cytokeratin-18 and its relation to liver fibrosis and steatosis diagnosed by FibroScan and controlled attenuation parameter in nonalcoholic fatty liver disease and hepatitis C virus patients.血清细胞角蛋白-18及其与非酒精性脂肪性肝病和丙型肝炎病毒患者通过FibroScan诊断的肝纤维化及受控衰减参数测定的肝脂肪变性的关系。
Eur J Gastroenterol Hepatol. 2019 May;31(5):633-641. doi: 10.1097/MEG.0000000000001385.
6
Hyperuricemia as an independent risk factor for non-alcoholic fatty liver disease (NAFLD) progression evaluated using controlled attenuation parameter-transient elastography: Lesson learnt from tertiary referral center.使用受控衰减参数-瞬时弹性成像评估高尿酸血症作为非酒精性脂肪性肝病(NAFLD)进展的独立危险因素:来自三级转诊中心的经验教训。
Diabetes Metab Syndr. 2019 Jan-Feb;13(1):424-428. doi: 10.1016/j.dsx.2018.10.001. Epub 2018 Oct 10.
7
Non-invasive assessment of hepatic steatosis in patients with NAFLD using controlled attenuation parameter and 1H-MR spectroscopy.使用受控衰减参数和1H-磁共振波谱对非酒精性脂肪性肝病患者的肝脂肪变性进行无创评估。
PLoS One. 2014 Mar 17;9(3):e91987. doi: 10.1371/journal.pone.0091987. eCollection 2014.
8
Diagnostic accuracy of controlled attenuation parameter (CAP) as a non-invasive test for steatosis in suspected non-alcoholic fatty liver disease: a systematic review and meta-analysis.受控衰减参数(CAP)作为疑似非酒精性脂肪性肝病非侵入性检测手段用于诊断脂肪变的诊断准确性:系统评价和荟萃分析。
BMC Gastroenterol. 2019 Apr 8;19(1):51. doi: 10.1186/s12876-019-0961-9.
9
Controlled attenuation parameter and alcoholic hepatic steatosis: Diagnostic accuracy and role of alcohol detoxification.受控衰减参数与酒精性肝脂肪变性:诊断准确性及酒精解毒的作用。
J Hepatol. 2018 May;68(5):1025-1032. doi: 10.1016/j.jhep.2017.12.029. Epub 2018 Jan 16.
10
How Good Are Controlled Attenuation Parameter Scores from Fibroscan to Assess Steatosis, NASH, and Fibrosis?Fibroscan的受控衰减参数评分在评估肝脂肪变性、非酒精性脂肪性肝炎和肝纤维化方面的准确性如何?
Dig Dis Sci. 2021 Apr;66(4):1297-1305. doi: 10.1007/s10620-020-06269-4. Epub 2020 Apr 27.

引用本文的文献

1
Prognostic impact of systemic inflammation indicators on all-cause and CVD mortality in adults with MASLD.全身炎症指标对患有代谢相关脂肪性肝病的成年人全因死亡率和心血管疾病死亡率的预后影响。
BMC Gastroenterol. 2025 Jul 1;25(1):448. doi: 10.1186/s12876-025-04018-3.
2
Sleep behaviors and metabolic-associated fatty liver disease.睡眠行为与代谢相关脂肪性肝病
PLoS One. 2025 May 28;20(5):e0323715. doi: 10.1371/journal.pone.0323715. eCollection 2025.
3
The association between immunoinflammatory biomarkers NLR, PLR, LMR and nonalcoholic fatty liver disease: a systematic review and meta-analysis.

本文引用的文献

1
Gender differences in the prevalence of nonalcoholic fatty liver disease in the Northeast of Thailand: A population-based cross-sectional study.泰国东北部非酒精性脂肪性肝病患病率的性别差异:一项基于人群的横断面研究。
F1000Res. 2017 Sep 4;6:1630. doi: 10.12688/f1000research.12417.2. eCollection 2017.
2
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases.非酒精性脂肪性肝病的诊断与管理:美国肝病研究协会的实践指南
Hepatology. 2018 Jan;67(1):328-357. doi: 10.1002/hep.29367. Epub 2017 Sep 29.
3
Association between metabolic syndrome and liver histology among NAFLD patients without diabetes.
免疫炎症生物标志物中性粒细胞与淋巴细胞比值(NLR)、血小板与淋巴细胞比值(PLR)、淋巴细胞与单核细胞比值(LMR)与非酒精性脂肪性肝病之间的关联:一项系统评价和荟萃分析。
Clin Exp Med. 2025 Jan 15;25(1):39. doi: 10.1007/s10238-024-01539-1.
4
Relationship between Neutrophil-to-Lymphocyte Ratio and Liver Fibrosis in Nonalcoholic Fatty Liver Disease Among Adults in the United States: Data from the National Health and Nutrition Examination Survey 2017-2018.中性粒细胞与淋巴细胞比值与美国成年人非酒精性脂肪性肝病肝纤维化的关系:来自 2017-2018 年全国健康和营养调查的数据。
Turk J Gastroenterol. 2024 Apr;35(4):335-342. doi: 10.5152/tjg.2024.23231.
5
Prognostic Role of Neutrophil to Lymphocyte Ratio in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.中性粒细胞与淋巴细胞比值在非酒精性脂肪性肝病中的预后作用:系统评价和荟萃分析。
Can J Gastroenterol Hepatol. 2022 Sep 10;2022:1554079. doi: 10.1155/2022/1554079. eCollection 2022.
6
The Association of Nonalcoholic Fatty Liver Disease With Neutrophil-to-Lymphocyte Ratio and Neutrophil-Percentage-to-Albumin Ratio.非酒精性脂肪性肝病与中性粒细胞与淋巴细胞比值及中性粒细胞百分比与白蛋白比值的关联
Cureus. 2023 Jun 30;15(6):e41197. doi: 10.7759/cureus.41197. eCollection 2023 Jun.
7
Predictive Role of Neutrophil-Percentage-to-Albumin Ratio (NPAR) in Nonalcoholic Fatty Liver Disease and Advanced Liver Fibrosis in Nondiabetic US Adults: Evidence from NHANES 2017-2018.中性粒细胞与白蛋白比值(NPAR)对非酒精性脂肪性肝病和非糖尿病美国成年人中晚期肝纤维化的预测作用:来自 NHANES 2017-2018 的证据。
Nutrients. 2023 Apr 14;15(8):1892. doi: 10.3390/nu15081892.
8
The Role of Non-Alcoholic Fatty Liver Disease in Infections.非酒精性脂肪性肝病在感染中的作用。
Life (Basel). 2022 Dec 7;12(12):2052. doi: 10.3390/life12122052.
非糖尿病的非酒精性脂肪性肝病(NAFLD)患者中代谢综合征与肝脏组织学之间的关联
BMJ Open Gastroenterol. 2016 Nov 9;3(1):e000114. doi: 10.1136/bmjgast-2016-000114. eCollection 2016.
4
Metabolic syndrome is a risk factor for nonalcoholic fatty liver disease: evidence from a confirmatory factor analysis and structural equation modeling.代谢综合征是非酒精性脂肪性肝病的一个危险因素:来自验证性因子分析和结构方程模型的证据。
Eur Rev Med Pharmacol Sci. 2016 Oct;20(20):4313-4321.
5
Asian-Pacific Association for the Study of the Liver (APASL) consensus guidelines on invasive and non-invasive assessment of hepatic fibrosis: a 2016 update.亚太肝脏研究协会(APASL)关于肝纤维化侵入性和非侵入性评估的共识指南:2016年更新版
Hepatol Int. 2017 Jan;11(1):1-30. doi: 10.1007/s12072-016-9760-3. Epub 2016 Oct 6.
6
Transient elastography (FibroScan(®)) with controlled attenuation parameter in the assessment of liver steatosis and fibrosis in patients with nonalcoholic fatty liver disease - Where do we stand?非酒精性脂肪性肝病患者中使用受控衰减参数的瞬时弹性成像(FibroScan(®))评估肝脏脂肪变性和纤维化——我们目前的进展如何?
World J Gastroenterol. 2016 Aug 28;22(32):7236-51. doi: 10.3748/wjg.v22.i32.7236.
7
The Natural Course of Non-Alcoholic Fatty Liver Disease.非酒精性脂肪性肝病的自然病程。
Int J Mol Sci. 2016 May 20;17(5):774. doi: 10.3390/ijms17050774.
8
EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease.欧洲肝脏研究学会-欧洲糖尿病研究学会-欧洲肥胖症研究学会非酒精性脂肪性肝病管理临床实践指南
J Hepatol. 2016 Jun;64(6):1388-402. doi: 10.1016/j.jhep.2015.11.004. Epub 2016 Apr 7.
9
Steatosis Grade is the Most Important Risk Factor for Development of Endothelial Dysfunction in NAFLD.脂肪变性分级是NAFLD中内皮功能障碍发生的最重要危险因素。
Medicine (Baltimore). 2016 Apr;95(14):e3280. doi: 10.1097/MD.0000000000003280.
10
Controlled attenuation parameter for assessment of hepatic steatosis grades: a diagnostic meta-analysis.用于评估肝脂肪变性分级的受控衰减参数:一项诊断性荟萃分析
Int J Clin Exp Med. 2015 Oct 15;8(10):17654-63. eCollection 2015.